Fisher Scientific weighs unsolicited Bass offer
This article was originally published in Clinica
Executive Summary
Fisher Scientific International is refusing to comment on an unsolicited proposal from its largest shareholder, Trinity I Fund, the investment body associated with members of the Bass family.